Related Experiment Videos
Hyperlipidemia in tumor-bearing rats
Biochimica Et Biophysica Acta
|September 12, 1984
Summary
Tumor-bearing rats exhibit hyperlipidemia due to increased hepatic triacylglycerol production, not a clearance defect. This suggests impaired clearance of dietary fats contributes to elevated lipid levels in cancer.
Area of Science:
- Biochemistry
- Oncology
- Metabolic research
Background:
- Hyperlipidemia is observed in tumor-bearing animals, but its underlying mechanisms remain unclear.
- Understanding lipid metabolism alterations in cancer is crucial for metabolic research.
Purpose of the Study:
- To investigate the mechanisms of hyperlipidemia in tumor-bearing rats, focusing on triacylglycerol clearance and production.
- To differentiate between impaired lipid clearance and increased lipid production as causes of hyperlipidemia in cancer.
Main Methods:
- Measurement of triacylglycerol clearance and production rates in rats with transplantable sarcoma.
- Utilized Triton injection to assess triacylglycerol accumulation and radioactive tracers for fractional clearance and production.
- Compared lipid metabolism in tumor-bearing rats with normal control rats under fasted and fat-fed conditions.
Main Results:
- Tumor-bearing rats showed increased plasma very-low-density lipoprotein triacylglycerol, but not a primary clearance defect.
- Fractional clearance of radioactive triacylglycerols was reduced, yet overall turnover was likely maintained due to expanded plasma pools.
- Hepatic triacylglycerol flux was unchanged or increased, and post-prandial hyperlipidemia worsened after fat-feeding, indicating impaired exogenous triacylglycerol removal.
Conclusions:
- The hyperlipidemia in fasted tumor-bearing rats is linked to unchanged or increased hepatic triacylglycerol production, excluding a primary clearance defect.
- Impaired clearance of dietary fats contributes to hyperlipidemia, as evidenced by less efficient removal of exogenous triacylglycerols after fat-feeding.